+499.5%
MRNA vs RVTY
+57.1%
+442.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RVTY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.3% | -1.9% | -1.9% |
| 7D | +5.5% | +1.1% | +4.4% | +3.8% |
| 30D | +158.7% | +13.2% | +145.5% | +126.6% |
| 3M | +182.1% | +27.2% | +154.9% | +128.6% |
| 6M | +151.8% | +32.4% | +119.4% | +99.1% |
| YTD | +393.6% | +34.9% | +358.7% | +292.7% |
| 1Y | +499.5% | +52.4% | +447.1% | +322.6% |
| All | +499.5% | +57.1% | +442.4% | +322.6% |
Cumulative growth
Daily Returns
Daily percentage return beside RVTY.
Daily Out/Under-Performance
Portfolio return minus RVTY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RVTY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RVTY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling